Myriad Genetics stockholders elect two directors, ratify auditor, approve advisory compensation vote

MYRIAD GENETICS INC

S. Louise Phanstiel and Daniel M. Skovronsky elected as directors for terms expiring 2027.
Ernst & Young ratified as independent auditor for FY 2024 with 81.5M votes for, 2.9M against.
Advisory vote on executive compensation approved with 74.4M for, 4.1M against.
Approximately 93% of outstanding shares present at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.